IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA in Patients with Relapsed...

Fort Bend Herald and Texas Coaster | Rosenberg

Nov 2, 2022

MOUNTAIN VIEW, Calif. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Nov 2, 2022-- |!| Rosenberg